Revenue up 54% but NPAT collapsed 89% as equity shrank NZD 371.9m

What changed

Revenue rose 54.4% to NZD 588.9m, yet earnings went the other way. Profit before tax fell 85.1% to NZD 13.4m, and NPAT fell 88.5% to NZD 7.4m, with a small NZD 0.4m loss from discontinued operations sitting below PBT. Operating cash flow declined 29.2% to NZD 42.3m, but capex was cut sharply from NZD 101.7m to NZD 17.5m, lifting pre-lease free cash flow to +NZD 24.8m from –NZD 42.0m. The balance sheet contracted materially: total assets fell 57.0% to NZD 457.1m and total equity fell 68.3% to NZD 172.8m, while gross borrowings rose to NZD 162.7m and net debt increased to NZD 141.7m from NZD 66.7m. Inventories collapsed from NZD 209.8m to NZD 55.0m. The announced final dividend was cut 90% to NZD 0.02 per share.

What matters

• Earnings quality deteriorated far faster than revenue suggests. On a 54% revenue uplift, PBT fell 85% and ROE dropped from 11.8% to 2.1%. The effective tax rate also jumped from 27.8% to 41.2%, making PBT the cleaner read — and it is still a collapse.
• Balance sheet direction reversed. Equity fell NZD 371.9m and total assets fell NZD 606.2m in a single year, well beyond what the NZD 0.4m discontinued-operations loss explains. Gross borrowings more than doubled from NZD 73.3m to NZD 162.7m, and net debt rose 112% to NZD 141.7m. Leverage weakened, and because current EBITDA is not disclosed, net debt/EBITDA cannot be refreshed.
• Segment mix is unflattering. Distribution is the largest revenue contributor at ~39.7% but the lowest-margin segment at ~5.6%, versus Manufacturing at ~9.7% and Storage & Logistics at ~8.4%. Group result is being anchored by the lowest-quality revenue stream.

Expectations

No quantitative forward-work, order book or earnings guidance was disclosed, and the filing includes no stated targets. What shape context exists is discouraging: HY24 NPAT was NZD 33.4m, yet full-year NPAT is NZD 7.4m, implying a second-half NPAT of roughly –NZD 26.0m. HY24 revenue was 34.5% of the full year, so the top line strengthened into H2, but profitability clearly did not. The release does not support a view that H2 run-rate earnings resemble H1, and it does not provide enough forward context to size FY25.

Quality of result

The positive FCF swing is largely a capex step-down (capex/revenue fell from 26.7% to 3.0%) rather than an operating cash improvement — operating cash flow itself fell 29%. Inventory days compressed from ~201 to ~34, so working capital released ~NZD 128m on partial measures; this is a one-off unwind of the FY23 stock build, not a repeatable tailwind. FCF/NPAT of 334% therefore overstates underlying cash generation. Earnings themselves look low-quality: the PBT–NPAT gap is amplified by a 13pp rise in the effective tax rate, and the NZD 371.9m equity reduction paired with a 57% fall in total assets points to impairments or disposals that the supplied extract does not fully bridge. The 90% final dividend cut is consistent with management reading the result the same way.

Unresolved

• What drove the NZD 606m drop in total assets and NZD 372m drop in equity? A NZD 0.4m discontinued-operations loss cannot account for it, and no impairment or divestment reconciliation is in the supplied extract.
• Why did the effective tax rate jump to 41.2%, and is that rate structural or one-off?
• What is FY24 EBITDA, and therefore where does net debt/EBITDA sit now versus the FY23 ratio of 0.52x?
• Is the capex step-down from NZD 101.7m to NZD 17.5m a deliberate pause, a funding constraint, or the end of a specific project cycle?
• Is the NZD 0.02 final dividend the entire FY24 distribution, or only the announcement component alongside an earlier interim?

This briefing cannot assess valuation, segment year-on-year trends, or the specific transactions behind the asset and equity reduction, because share-price data, comparable prior-period segment disclosures, and impairment/disposal detail were not supplied.

Key metrics

Segment breakdown

Analytical metrics

This analysis was generated using Annolyse, an AI-powered tool that analyses NZX company announcements. The analysis is based on available company filings and standard Annolyse calculations. This is general information only and does not constitute financial advice. The analysis may contain errors. Always read the original company filings and consult a licensed financial adviser before making investment decisions.